The Defense Production Act (DPA) and COVID-19: Key Authorities and Policy Considerations
Abstract
As the coronavirus (COVID-19) pandemic evolves, the United States faces drug and medical supply scarcities due to disrupted supply chains and increased demand. In response, the President may exercise emergency authorities under the Defense Production Act of 1950 (DPA; 50 U.S.C. sections 4501 et seq.) to address supply shortages and economic development impacts. During a press conference on March 18, 2020, the President indicated that he would invoke the DPA to address domestic essential goods and materials shortages caused by the pandemic. This Insight considers the various DPA authorities that maybe used going forward and explores potential policy considerations for Congress.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 18, 2020
- Accession Number
- AD1169964
Entities
People
- Heidi M. Peters
- Michael H. Cecire
Organizations
- Library of Congress